Robert Califf’s FDA with Maddie Bannon
Unlimited Hangout with Whitney Webb
00:00
The Future of Neuromodulation
The breakthrough device designation also allows for novel medical devices, they call it de novo. So we have a lot of companies are looking at the screen, um, saying, what does that nerve hold? There's a certain nerve that originates at the screen and it's part of the autonomic nerve system. One company pursuing neural modulation of that particular nerve is Galvani by electronics. And of course, Verily is also the people behind Project baseline, which is something that you mentioned earlier.
Transcript
Play full episode
